Study identifies those at high risk for developing pancreatic cancer
the ONA take:
According to new findings published in the journal Digestive and Liver Diseases, an international team of researchers has developed a profile of the patient who would be at highest risk for developing pancreatic lesions that are most likely to develop into cancer.
To determine which patients are at high risk, the researchers analyzed data from 1,126 patients diagnosed with pancreatic lesions.
Of those, 84 developed invasive pancreatic cancer. Results showed that all 84 patients had all or some of the following factors: a history of smoking, a history of obesity, jaundice, and steatorrhea.
Researchers also identified the following risk factors: a larger cyst size, cysts in the main pancreatic duct, and nodules on the cyst wall. The study showed that abdominal pain did not put patients at high risk.
The authors estimate that between 10 and 40% of people have these lesions, but the majority do not develop pancreatic cancer.
The findings may help assure concerned patients who have these lesions that they are not at high risk for developing pancreatic cancer.
Researchers developed a profile of the patient who would be at highest risk for developing pancreatic lesions.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|